A publicly traded Danish medical marijuana operator Stenocare and German cannabis-focused pharma company ADREXpharma are ready to deliver a new and innovative medical cannabis...
A somewhat bizarre story when you look at the directors, why they can’t manage to raise that amount seems a...
Second quarter 2024 revenue of $342 million, representing an increase of 2% year-over-year and adjusted gross margin(1) of 48% Second quarter...
The Vermont Department of Taxes Aug 1 released the Vermont Cannabis Tax Guide (GB-1313), which provides information on the taxation...
Cannabis retailer Cresco Labs Inc. said Thursday its second-quarter loss widened on a $61 million charge related to its tax...
TESTSTSARDSAR Legal Global Cannabis Products Are Becoming More Diverse by Hazel Norman As the legal cannabis industry continues to expand...
Lucid News The FDA has rejected Lykos Therapeutics’ New Drug Application (NDA) for MDMA-assisted therapy for PTSD. The agency issued...
Lucid News On July 16, the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) responded to the FDA Advisory Committee (AdComm) recommendation...
MAPS remains confident in its goal of making access to MDMA-assisted therapy for PTSD safe and legal Aug 9, 2024...
Here’s the introduction to the piece in, “The Conversation” An operations manager finds relief from her depression with the help of psilocybin,...